Vascular diseases await translation of blood vessels engineered from stem cells
View/ Open
Published Version
https://doi.org/10.1126/scitranslmed.aaa1805Metadata
Show full item recordCitation
Samuel, R., D. G. Duda, D. Fukumura, and R. K. Jain. 2015. “Vascular Diseases Await Translation of Blood Vessels Engineered from Stem Cells.” Science Translational Medicine 7 (309) (October 14): 309rv6–309rv6. doi:10.1126/scitranslmed.aaa1805.Abstract
The discovery of human induced pluripotent stem cells (hiPSCs) opened new avenues for research and potential clinical applications for tissue regeneration and engineering. In particular,hiPSCs may offer a long sought solution for obtaining large numbers of autologous cells sufficient for tissue engineering. For vascular tissue engineering, several methods of generating endothelial cells or perivascular cells from hiPSCs in vitro have been reported. We review the current developments in the generation of vascular progenitor cells from hiPSCs and their functional capacity in vivo, and discuss the opportunities and challenges ahead for clinical translation and modeling vascular diseases using hiPSC-derived vascular cells with a focus on diabetes.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799660/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:37133882
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)